FLOBIO
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis. The company was founded in 2017 and is headquartered in Philadelphia, PA.
FLOBIO
Social Links:
Industry:
Health Care Medical Medical Device
Founded:
2017-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.flobiollc.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
256 K USD
Similar Organizations
3i Nanotech
3i Nanotech develops point-of-care platform technology to track protein biomarkers in human samples.
Articulate Biosciences
Articulate Biosciences develops viscoelastic gels for injection to treat arthritis and other soft tissue diseases.
BLOCKsyncop
BLOCKsyncop is developing a non-invasive real-time tool for the anesthesiologist.
Cholestech
Cholestech develops point-of-care diagnostics solutions for chronic diseases.
Clearsight
ClearSight develops intraocular lenses for high-quality vision after cataract surgery.
Dechoker
Dechoker develops an airway clearance device for emergency situations.
EyeNetra
EyeNetra is a developer of an eye diagnostics platform used to measure the correction of users' vision through smartphone-based technology.
FastDetect
FastDetect develops diagnostic equipment designed for testing COVID-19.
G Medical Innovations
G Medical Innovations is a next-generation mobile health (mHealth) and e-health company.
SciLogica
SciLogica is a developer of a blood parameter monitoring platform used in evaluating and providing real-time blood parameter measurements.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - FloBio
Official Site Inspections
http://www.flobiollc.com
- Host name: 192.0.78.175
- IP address: 192.0.78.175
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "FloBio"
About FloBio - FloBio
FloBio / About FloBio Reimagining Hemostasis Testing By Filling The Information Gap To Impact Clinical Decision Making FloBio LLC, formed in August 2017 as a spin-out of the University of Pennsylvania (UOP), is pioneering a novel fluidic …See details»
FloBio - Crunchbase Company Profile & Funding
Contact Email [email protected] FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis. The company was founded in …See details»
Contact Us - FloBio
FloBio LLC. 3401 Grays Ferry Avenue, Building 450. Philadelphia, PA 19146See details»
FloBio LLC - LinkedIn
FloBio LLC | 214 followers on LinkedIn. FloBio is developing point-of-care diagnostics using real-time analysis of flowing blood for bleeding/thrombotic risk | FloBio is pioneering a novel point ...See details»
FloBio Company Profile | Management and Employees List
Www.flobiollc.com . FloBio Profile and History. FloBio is pioneering a novel point-of-care diagnostic platform that analyzes flowing blood to assess blood clotting function under …See details»
FloBio Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for FloBio. Use the PitchBook Platform to explore the full profile.See details»
FloBio LLC | Philadelphia, PA, USA Startup - gust.com
Website flobiollc.com; Company Summary FloBio is pioneering a game changing point-of-care diagnostic that assesses blood clotting function in emergency critical care patients. Rapid …See details»
FLOBIO LLC Company Profile | Philadelphia, PA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FLOBIO LLC of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
FloBio, LLC - Drug pipelines, Patents, Clinical trials - Synapse
Feb 29, 2024 Explore FloBio, LLC with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
FloBio LLC Overview - Salary.com
Discover essential details about FloBio LLC, including address, contact, and journey of our company's evolution.See details»
FloBio LLC - Company Profile & Staff Directory - ContactOut
FloBio is pioneering a novel point of care (POC) blood diagnostic platform that assesses blood biology and clotting status under physiologic, dynamic flow. Our proprietary microfluidic …See details»
Flobio Company Profile -Sales, Contacts, Competitors – Buzzfile
Flobio is in the Commercial Physical Research industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 7 years.See details»
FLOBIO LLC - VentureRadar
Amount: $1,222,556.00 | A rapid microfluidic diagnostic assay for the measurement of Direct Oral Anticoagulants from patient whole blood | From: 2022-05-01 to 2023-10-31See details»
FloBio - Contacts, Employees, Board Members, Advisors & Alumni
Edit Board Member and Advisor Profiles Section. Number of Board Member and Advisor Profiles 2. FloBio has 2 board members and advisors, including Sasha Schrode.See details»
News - FloBio
FloBio / News Latest News October 2023 – FloBio Receives FDA’s Breakthrough Device Designation For Bleeding Risk Diagnostic Test. Rapid Detection of Modern Blood Thinners …See details»
Financial Conflict of Interest Policy - flobiollc.com
POL-20220407-01 Page 1 of 8 CONFIDENTIAL Financial Conflict of Interest Policy FloBio, LLC. requires that each investigator, subrecipient, subgrantee and collaboratorSee details»
How much do FloBio LLC employees make? - Salary.com
The average annual salary of FloBio LLC is estimated to be approximate $45 per year. The majority pay is between $40 to $51 per year. Visit Salary.com to find out FloBio LLC salary, …See details»
Our Technology - FloBio
FloBio / Our Platform & Technology Developing A 1st Of Its Kind Point-of Care Functional Hemostasis Diagnostic Platform Easily adaptable with broad clinical utility Patent Pending …See details»
FloBio receives FDAs Breakthrough Device Designation - FloBio
PHILADELPHIA, October 17, 2023 — FloBio, a medical diagnostics company, announced today that the U.S. Food and Drug Administration has granted Breakthrough Device Designation for …See details»